Overview
This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.
Eligibility
- Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay
- Age ≥18 years
- Provision of written ICF
- Clinical diagnosis of cardiogenic shock.
- impaired organ perfusion due to primary cardiac dysfunction,
- persistent systolic blood pressure (SBP) \<90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and
- evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following:
- Cold or clammy extremities
- Altered mental status
- Reduced urine output
- Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring)
- Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded
Exclusion criteria:
- Age \<18 years
- Refusal to provide informed consent by the patient or their legally authorized representative
